Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05119439 · ClinicalTrials.gov registry record · Phase 4
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
A Phase 4 study, sponsored by Gynuity Health Projects.
- Terminated
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT05119439 is a Phase 4 study that was terminated before completion, run by Gynuity Health Projects. The registered enrollment target is 23 participants.
The verdict
NCT05119439, a Phase 4 study, was terminated before completion, sponsored by Gynuity Health Projects.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first trimester of pregnancy.
Interventions
- DRUG Mifepristone + 2 doses of misoprostol 800 mcg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-10-07 |
| Est. Completion | 2023-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05119439
The ClinicalTrials.gov registry entry for NCT05119439 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifepristone + 2 doses of misoprostol 800 mcg is the first listed.
NCT05119439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05119439 about?
NCT05119439 is a clinical study titled "Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks". This study seeks to evaluate the efficacy, side effect profile and acceptability of a medical abortion regimen with mifepristone and two doses of 800 mcg misoprostol buccally at 71-77 and 78-84 days of gestation to further expand the evidence base for the most effective regimens in the late first tr...
What is the current status of trial NCT05119439?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2022-10-07. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05119439?
The interventions under investigation include: Mifepristone + 2 doses of misoprostol 800 mcg (DRUG).
Who is sponsoring clinical trial NCT05119439?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.